Cargando…
Defining conversion therapy for esophageal squamous cell carcinoma
A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially u...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831898/ https://www.ncbi.nlm.nih.gov/pubmed/36643357 http://dx.doi.org/10.1002/ags3.12623 |
_version_ | 1784867947151360000 |
---|---|
author | Matsuda, Satoru Tsushima, Takahiro Kato, Ken Hsu, Chih‐Hung Lee, Jang Ming Wong, Ian Yu‐Hong Wang, Hu‐Lin Christina Kang, Chang Hyun Guo, Xufeng Yamamoto, Shun Tsuji, Takayuki Kawakubo, Hirofumi Takeuchi, Hiroya Law, Simon Kitagawa, Yuko |
author_facet | Matsuda, Satoru Tsushima, Takahiro Kato, Ken Hsu, Chih‐Hung Lee, Jang Ming Wong, Ian Yu‐Hong Wang, Hu‐Lin Christina Kang, Chang Hyun Guo, Xufeng Yamamoto, Shun Tsuji, Takayuki Kawakubo, Hirofumi Takeuchi, Hiroya Law, Simon Kitagawa, Yuko |
author_sort | Matsuda, Satoru |
collection | PubMed |
description | A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.[Image: see text] |
format | Online Article Text |
id | pubmed-9831898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98318982023-01-12 Defining conversion therapy for esophageal squamous cell carcinoma Matsuda, Satoru Tsushima, Takahiro Kato, Ken Hsu, Chih‐Hung Lee, Jang Ming Wong, Ian Yu‐Hong Wang, Hu‐Lin Christina Kang, Chang Hyun Guo, Xufeng Yamamoto, Shun Tsuji, Takayuki Kawakubo, Hirofumi Takeuchi, Hiroya Law, Simon Kitagawa, Yuko Ann Gastroenterol Surg Editorials A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.[Image: see text] John Wiley and Sons Inc. 2022-10-19 /pmc/articles/PMC9831898/ /pubmed/36643357 http://dx.doi.org/10.1002/ags3.12623 Text en © 2022 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorials Matsuda, Satoru Tsushima, Takahiro Kato, Ken Hsu, Chih‐Hung Lee, Jang Ming Wong, Ian Yu‐Hong Wang, Hu‐Lin Christina Kang, Chang Hyun Guo, Xufeng Yamamoto, Shun Tsuji, Takayuki Kawakubo, Hirofumi Takeuchi, Hiroya Law, Simon Kitagawa, Yuko Defining conversion therapy for esophageal squamous cell carcinoma |
title | Defining conversion therapy for esophageal squamous cell carcinoma |
title_full | Defining conversion therapy for esophageal squamous cell carcinoma |
title_fullStr | Defining conversion therapy for esophageal squamous cell carcinoma |
title_full_unstemmed | Defining conversion therapy for esophageal squamous cell carcinoma |
title_short | Defining conversion therapy for esophageal squamous cell carcinoma |
title_sort | defining conversion therapy for esophageal squamous cell carcinoma |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831898/ https://www.ncbi.nlm.nih.gov/pubmed/36643357 http://dx.doi.org/10.1002/ags3.12623 |
work_keys_str_mv | AT matsudasatoru definingconversiontherapyforesophagealsquamouscellcarcinoma AT tsushimatakahiro definingconversiontherapyforesophagealsquamouscellcarcinoma AT katoken definingconversiontherapyforesophagealsquamouscellcarcinoma AT hsuchihhung definingconversiontherapyforesophagealsquamouscellcarcinoma AT leejangming definingconversiontherapyforesophagealsquamouscellcarcinoma AT wongianyuhong definingconversiontherapyforesophagealsquamouscellcarcinoma AT wanghulinchristina definingconversiontherapyforesophagealsquamouscellcarcinoma AT kangchanghyun definingconversiontherapyforesophagealsquamouscellcarcinoma AT guoxufeng definingconversiontherapyforesophagealsquamouscellcarcinoma AT yamamotoshun definingconversiontherapyforesophagealsquamouscellcarcinoma AT tsujitakayuki definingconversiontherapyforesophagealsquamouscellcarcinoma AT kawakubohirofumi definingconversiontherapyforesophagealsquamouscellcarcinoma AT takeuchihiroya definingconversiontherapyforesophagealsquamouscellcarcinoma AT lawsimon definingconversiontherapyforesophagealsquamouscellcarcinoma AT kitagawayuko definingconversiontherapyforesophagealsquamouscellcarcinoma |